Investors Asset Management of Georgia’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,085
Closed -$82K 407
2022
Q3
$82K Sell
1,085
-75
-6% -$6.22K 0.04% 238
2022
Q2
$98K Buy
+1,160
New +$102K 0.05% 205

Other funds holding NVS

Investors Asset Management of Georgia's NVS Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Novartis (NVS) in Q4 2022, closing a stake of 1,085 shares — an estimated $82K sold.

Investors Asset Management of Georgia first reported a position in NVS in Q2 2022 and held it in 2 quarters. The position peaked at $98K in Q2 2022. 1,184 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining Novartis position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 1,085 Novartis shares in Q4 2022, an estimated $82K.
  • Investors Asset Management of Georgia first reported a position in Novartis in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's Novartis position peaked at $98K in Q2 2022.
  • 1,184 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.